After being awarded in 2019 by The National Science Foundation (NSF) with a $225,000 Phase I grant in support for continuing work on developing technology for COPD, Respira Labs is honored to announce that its founder, Dr. Maria Artunduaga has secured a ~$1M Phase II grant, one of the most competitive grants for a latina, immigrant and solo founder, physician and principal investigator in the history of The National Science Foundation (NSF), bringing a total funding to $2M (80% non-dilutive) for Respira Labs.
Here’s what the founder has to say about her recent achievement:
“It’s been a long and arduous journey, leaving plastic surgery after realizing I’d never be able to unleash my full potential facing all sorts of biases for being who I am, retraining in my mid-thirties and repurposing my life towards solving the biggest technological gap in respiratory health, accurate diagnostics for lung function decline outside of the hospital, what ultimately took my grandmother’s life.”
Respira Labs is committed to continuing research and development of technologies that aid in the diagnosis and adequate treatment in COPD patients and COVID survivors.
If you are interested in working for Respira Labs, please contact Dr. Maria Artunduaga at firstname.lastname@example.org.